0001161697-23-000221.txt : 20230403 0001161697-23-000221.hdr.sgml : 20230403 20230403204742 ACCESSION NUMBER: 0001161697-23-000221 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210512 FILED AS OF DATE: 20230403 DATE AS OF CHANGE: 20230403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KATZAROFF JAMES C CENTRAL INDEX KEY: 0001286868 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55072 FILM NUMBER: 23794800 MAIL ADDRESS: STREET 1: 719 JADWIN AVE. CITY: RICHLAND STATE: WA ZIP: 99352 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GlobeStar Therapeutics Corp CENTRAL INDEX KEY: 0001502152 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 273480481 STATE OF INCORPORATION: WY FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 719 JADWIN AVENUE CITY: RICHLAND STATE: WA ZIP: 99352 BUSINESS PHONE: 509-531-1671 MAIL ADDRESS: STREET 1: 719 JADWIN AVENUE CITY: RICHLAND STATE: WA ZIP: 99352 FORMER COMPANY: FORMER CONFORMED NAME: AngioSoma, Inc. DATE OF NAME CHANGE: 20160622 FORMER COMPANY: FORMER CONFORMED NAME: First Titan Corp. DATE OF NAME CHANGE: 20100927 4 1 form_4.xml FORM 4 FOR 05-12-2021 X0407 4 2021-05-12 0 0001502152 GlobeStar Therapeutics Corp GSTC 0001286868 KATZAROFF JAMES C 719 JADWIN AVE. RICHLAND WA 99352 1 1 0 0 CEO 0 Common stock 2023-04-03 2023-04-03 4 J 0 70422535 .0071 A 80422535 D Options .03 2021-05-12 4 A 0 30000000 0 A 2021-05-12 2023-05-12 Common stock 30000000 30000000 D Options .009 2023-02-24 4 A 0 35000000 0 A 2023-08-24 2028-02-24 Common stock 35000000 65000000 D Shares acquired pursuant to conversion of debt of $50,000. Options vest 50% when granted and balance ratably on a daily basis during the 24 month period commencing on date of grant. Vested Options are exercisable 6 months after date of grant and thereafter until 5 years after the date of grant. James C. Katzaroff 2023-04-03